Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 67 peer-reviewed journal articles Updated
Endocrinology

Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency: A Patient Guide

At a Glance

3-beta-HSD deficiency is a rare form of congenital adrenal hyperplasia that disrupts cortisol and aldosterone production and can affect reproductive development. Lifelong hormone replacement, stress dosing during illness or injury, and endocrinology follow-up are central to care and help prevent adrenal crisis.

Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase (3β-HSD) deficiency is an exceptionally rare genetic condition that fundamentally changes how the body’s “chemical factories”—the adrenal glands and the gonads—produce essential hormones [1]. Because the condition is so rare, much of what the medical community knows comes from small clinical case series rather than large population studies.

In most people, these organs use a specific enzyme to convert early-stage biochemical building blocks into mature hormones like cortisol, which manages the stress response, and aldosterone, which regulates salt and blood pressure. For those with 3β-HSD deficiency, a genetic mutation creates a biological “block” that prevents these conversions from happening correctly. This leads to a complex imbalance where the body is starved of vital mature hormones while being flooded with early-stage precursor steroids [2][3].

This condition is distinct from the more common forms of CAH because the enzyme block occurs so early in the hormone-making process that it directly affects the development of the reproductive system as well as the adrenal system [4]. While other types of CAH typically lead to the overproduction of potent adrenal androgens, 3β-HSD deficiency often results in an “undervirilization” of genetic males, meaning they may be born with atypical or ambiguous genitalia because they cannot produce enough testosterone during fetal development. Conversely, genetic females typically have normal or only mildly changed physical appearances at birth [5][6]. Understanding this unique biological “fingerprint” is essential, as standard medical tests designed for common CAH can sometimes be misleading for individuals with this specific deficiency [7].

Living with 3β-HSD deficiency requires a lifelong commitment to precision medicine. To replace what the body cannot make, daily medications are used to maintain energy levels, balance blood minerals, and support healthy growth [8][9]. Beyond daily maintenance, a critical part of care is “stress dosing”—providing extra medication during periods of illness or physical injury to prevent a dangerous drop in blood pressure known as an adrenal crisis. Because this condition is so rare, specialized monitoring by an endocrinologist is vital to navigate the delicate balance of hormone replacement while protecting long-term growth and development [10][11].

While the diagnosis may initially feel overwhelming, many children and adults do well with reliable treatment and follow-up [12]. As medical understanding of these rare genetic pathways continues to advance, the focus remains on empowering families with the knowledge needed to manage the condition effectively. By becoming an advocate for your or your child’s unique needs, you ensure access to the tailored care required for this specific biological journey [13].

In this guide

6 chapters

01

Understanding Your Diagnosis: 3β-HSD deficiency

Learn what 3β-HSD deficiency means, how it differs from common CAH, salt-wasting, genetics, rarity, and questions to discuss with your healthcare team.

02

Recognizing Red Flags: Symptoms & Adrenal Crisis

Learn to recognize adrenal crisis signs in 3-beta-HSD deficiency, when to give emergency hydrocortisone, and which symptoms need routine endocrine review.

03

The Biology of 3β-HSD: How the Diagnosis is Made

Learn how 3β-HSD deficiency is diagnosed, including newborn-screen limits, hormone ratios, LC-MS/MS, ACTH stimulation, and how HSD3B2 genetic results guide care.

04

Sex Characteristics & Genital Development

Learn how congenital adrenal hyperplasia due to 3β-HSD deficiency affects genital development, puberty, DSD team care, and thoughtful decisions about surgery.

05

Standard Treatment & Daily Medications

Learn how 3β-HSD deficiency is treated with hydrocortisone, fludrocortisone, stress dosing, and monitoring to prevent adrenal crisis and avoid overreplacement.

06

Long-term Monitoring & Adulthood

Learn how 3β-HSD deficiency is monitored from childhood to adulthood, including growth, hormone tests, TART screening, periods, fertility, and stress dosing.

Common questions in this guide

What is 3-beta-HSD deficiency?
3-beta-HSD deficiency is a rare genetic form of congenital adrenal hyperplasia. The enzyme problem disrupts the adrenal glands’ and gonads’ ability to make mature hormones such as cortisol and aldosterone, while early hormone building blocks accumulate.
How is 3-beta-HSD deficiency different from other types of CAH?
The enzyme block occurs very early in hormone production, so it can affect both the adrenal system and reproductive development. Genetic males may be born with atypical or ambiguous genitalia, while genetic females often have normal or only mildly changed appearance at birth.
Why can standard CAH blood tests be misleading?
3-beta-HSD deficiency creates a distinct pattern of low mature hormones and increased precursor steroids. Tests designed for more common forms of CAH may not capture that pattern accurately, so an endocrinologist should interpret laboratory results in the context of the specific diagnosis.
What treatment does 3-beta-HSD deficiency require?
Treatment involves lifelong daily hormone replacement to support energy, salt and fluid balance, and healthy growth. The care team also uses extra medication during illness or injury, known as stress dosing, to reduce the risk of adrenal crisis.
What is stress dosing, and when is it needed?
Stress dosing means taking extra replacement medicine when the body is under stress from illness or physical injury. It helps prevent a dangerous fall in blood pressure called an adrenal crisis, and the exact instructions should come from the treating endocrinology team.
Which specialists should be involved in care for 3-beta-HSD deficiency?
An endocrinologist should be central to care because this condition affects adrenal hormone production, salt and blood pressure regulation, growth, and reproductive development. Other specialists may be added based on the person’s age and individual needs.
Can children and adults with 3-beta-HSD deficiency live well?
Many children and adults do well when they take replacement treatment consistently and attend regular specialist follow-up. Ongoing monitoring helps the care team balance hormone replacement with healthy growth and development.

Get notified when new evidence is published on Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (13)
  1. 1

    Clinical perspectives in congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase type 2 deficiency.

    Al Alawi AM, Nordenström A, Falhammar H

    Endocrine 2019; (63(3)):407-421 doi:10.1007/s12020-018-01835-3.

    PMID: 30719691
  2. 2

    Development of monoclonal antibodies against the human 3β-hydroxysteroid dehydrogenase/isomerase isozymes.

    Gomez-Sanchez CE, Lewis M, Nanba K, et al.

    Steroids 2017; (127()):56-61 doi:10.1016/j.steroids.2017.08.011.

    PMID: 28863887
  3. 3

    Late diagnosis of 3β-Hydroxysteroid dehydrogenase deficiency: the pivotal role of gas chromatography-mass spectrometry urinary steroid metabolome analysis and a novel homozygous nonsense mutation in the HSD3B2 gene.

    Fanis P, Neocleous V, Kosta K, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2021; (34(1)):131-136 doi:10.1515/jpem-2020-0245.

    PMID: 33180036
  4. 4

    Congenital adrenal hyperplasia: clinical symptoms and diagnostic methods.

    Podgórski R, Aebisher D, Stompor M, et al.

    Acta biochimica Polonica 2018; (65(1)):25-33 doi:10.18388/abp.2017_2343.

    PMID: 29543924
  5. 5

    Revisiting Classical 3β-hydroxysteroid Dehydrogenase 2 Deficiency: Lessons from 31 Pediatric Cases.

    Guran T, Kara C, Yildiz M, et al.

    The Journal of clinical endocrinology and metabolism 2020; (105(3)) doi:10.1210/clinem/dgaa022.

    PMID: 31950145
  6. 6

    Disorders of Sex Development of Adrenal Origin.

    Finkielstain GP, Vieites A, Bergadá I, Rey RA

    Frontiers in endocrinology 2021; (12()):770782 doi:10.3389/fendo.2021.770782.

    PMID: 34987475
  7. 7

    Congenital Adrenal Hyperplasia: Time to Replace 17OHP with 21-Deoxycortisol.

    Miller WL

    Hormone research in paediatrics 2019; (91(6)):416-420 doi:10.1159/000501396.

    PMID: 31450227
  8. 8

    Positive neonatal screening test for congenital adrenal hyperplasia in a case with 3β-hydroxysteroid dehydrogenase type 2 deficiency.

    Anik M, Erdogan D, Baris T, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2026; (39(2)):193-198 doi:10.1515/jpem-2025-0403.

    PMID: 41111433
  9. 9

    Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline.

    Bornstein SR, Allolio B, Arlt W, et al.

    The Journal of clinical endocrinology and metabolism 2016; (101(2)):364-89 doi:10.1210/jc.2015-1710.

    PMID: 26760044
  10. 10

    Management of Acute Adrenal Insufficiency-Related Adverse Events in Children with Congenital Adrenal Hyperplasia: Results of an International Survey of Specialist Centres.

    Ali SR, Bryce J, Krone NP, et al.

    Hormone research in paediatrics 2022; (95(4)):363-373 doi:10.1159/000525075.

    PMID: 35569445
  11. 11

    Glucocorticoid reduction after starting crinecerfont in pediatric patients with classic congenital adrenal hyperplasia: practical perspectives.

    Nokoff NJ, Fechner PY, Kim MS, et al.

    The Journal of clinical endocrinology and metabolism 2026; (111(8)):e1937-e1950 doi:10.1210/clinem/dgag192.

    PMID: 42082437
  12. 12

    3β-Hydroxysteroid dehydrogenase type-2 deficiency: Our experience and gonadal function-focused systematic review.

    Daga A, Phadte A, Karlekar M, et al.

    Endocrine 2026; (91(1)).

    PMID: 41920275
  13. 13

    How parents of children with ataxia-telangiectasia use dynamic coping to navigate cyclical uncertainty.

    Schiller J, Towne MC, Epstein R, et al.

    Journal of genetic counseling 2024; (33(2)):301-313 doi:10.1002/jgc4.1727.

    PMID: 37183503

This page is for informational purposes only and does not constitute medical advice. Your endocrinology team should guide hormone replacement, stress dosing, emergency planning, and follow-up for your or your child’s specific situation.